Cuiling Feng
Overview
Explore the profile of Cuiling Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou X, Gao J, Zhang Y, Feng C
Funct Integr Genomics
. 2025 Feb;
25(1):47.
PMID: 40019596
Shenling Baizhu Powder (SLBZP), commonly used as a complementary and alternative therapy for lung adenocarcinoma (LUAD), is believed to enhance patients' immune function. However, its underlying mechanisms remain unclear. By...
2.
Shu X, Xu D, Qu Y, Shang X, Qiao K, Feng C, et al.
Front Pharmacol
. 2024 Aug;
15:1428216.
PMID: 39193337
is a traditional Chinese medicine that has shown promise for the management of chronic bronchitis (CB). We aim to assess the efficacy and safety of a preparation of named Bailing...
3.
Zheng M, Zhu W, Gao F, Zhuo Y, Zheng M, Wu G, et al.
J Nanobiotechnology
. 2024 Mar;
22(1):136.
PMID: 38553716
Pulmonary fibrosis (PF) threatens millions of people worldwide with its irreversible progression. Although the underlying pathogenesis of PF is not fully understood, there is evidence to suggest that the disease...
4.
Zheng M, Liu K, Li L, Feng C, Wu G
J Nanobiotechnology
. 2024 Jan;
22(1):14.
PMID: 38166847
Idiopathic pulmonary fibrosis (IPF) is a highly debilitating and fatal chronic lung disease that is difficult to cure clinically. IPF is characterized by a gradual decline in lung function, which...
5.
Wang H, Wang G, Meng Y, Liu Y, Yao X, Feng C
Phytomedicine
. 2023 Dec;
123:155211.
PMID: 38061286
Background/purpose: Exposure to particles with an aerodynamic diameter of ≤2.5 μm (PM2.5) increased various lung diseases, which lack effective treatment. Massive evidence links PM2.5 to the development of allergic lung...
6.
Zheng M, Li L, Chen L, Li B, Feng C
Sci Rep
. 2023 May;
13(1):8597.
PMID: 37237159
To assess the clinical value of mechanical thrombectomy (MT) combined with intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) by comparing it with the MT alone. In this study, we...
7.
Shi L, Yan J, Meng Y, Wang G, Du J, Feng C
Evid Based Complement Alternat Med
. 2022 Dec;
2022:1129567.
PMID: 36523421
Objective: To explore the effects and mechanisms of Bufei Huoxue Capsule (BHC) on chronic obstructive pulmonary disease (COPD) based on network pharmacology. Methods: The effective components and related targets of...
8.
Wang G, Zhou B, Wang Z, Meng Y, Liu Y, Yao X, et al.
Front Mol Biosci
. 2021 May;
8:644561.
PMID: 33968984
Background: Asthma is a chronic inflammatory disease characterized by Th2-predominant inflammation and airway remodeling. Modified Guo Min decoction (MGMD) has been an extensive practical strategy for allergic disorders in China....
9.
Ma Y, Feng C, Wang J, Chen Z, Wei P, Fan A, et al.
Oncol Lett
. 2019 Mar;
17(3):3503-3510.
PMID: 30867790
Hepatocellular carcinoma (HCC) is a serious threat to human health. Chemotherapy drugs such as cisplatin are widely used in cancer treatment, but can cause severe side effects. Hydroxyl safflower yellow...
10.
Feng F, Du J, Meng Y, Guo F, Feng C
Evid Based Complement Alternat Med
. 2019 Feb;
2019:6471815.
PMID: 30800170
Airway mucus hypersecretion is the main pathogenic factor in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and the control of mucus secretion is closely associated with survival. Louqin Zhisou...